Intra Articular Distal Humerus FractureNCT07860970
Comparison of Functional Outcomes Between Triceps Tongue Elevation vs Olecranon Osteotomy in Intra Articular Distal Humerus Fracture (IA-DH) Management
A study testing Triceps tongue elevation and Olecranon osteotomy in people with Intra Articular Distal Humerus Fracture, run by Rawalpindi Teaching Hospital, District Headquarter Hospital, Rawalpindi at 1 site in Pakistan.
Trial summary
Comparison of triceps tongue elevation vs olecranon osteotomy in intra articular distal humerus fracture management by doing Randomized control trial in trauma and orthopedic surgery department of Rawalpindi Teaching Hospital involving participants are 102 in 9 month duration by using MEPI score. Read more about this study
- Who is it for?
- Ages 15 to 75 years
- Conditions the study is for
- Intra Articular Distal Humerus Fracture
- What is being tested?
- Triceps tongue elevation and Olecranon osteotomy
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 102 participants
- Where
- 1 sitePakistan
- Study dates
- 19 Sep 2026to 19 May 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 75 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Both Gender . Age 15-75 Years . (?) Radiologically confirmed intra-articular distal humerus fractures r Patients presenting within 7 days of injury
Who cannot join
- Open fractures (Gustilo-Anderson Grade II or higher) . Pathological fractures (e.g., due to tumors or metabolic bone disease) r Previous elbow surgery or deformity on the affected limb Patients with associated neurovascular injury o Patients with comorbidities impairing rehabilitation (e.g., severe stroke, advanced arthritis) . Non-compliance with follow-up protocol
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site
Rawalpindi Teaching Hospital
Rawalpindi, Punjab Province, 46000
About this study
Comparison of triceps tongue elevation vs olecranon osteotomy in intra articular distal humerus fracture management by doing Randomized control trial in trauma and orthopedic surgery department of Rawalpindi Teaching Hospital involving participants are 102 in 9 month duration by using MEPI score.
Read the detailed description
Comparison of triceps tongue elevation vs olecranon osteotomy in intra articular distal humerus fracture management by doing Randomized control trial in trauma and orthopedic surgery department of Rawalpindi Teaching Hospital involving participants are 102 with 51 in each in 9 month duration by using MEPI score.
- Conditions
- Intra Articular Distal Humerus Fracture
- Being tested
- Triceps tongue elevation, Olecranon osteotomy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Triceps tongue elevationProcedure or surgery
Compare the outcomes of triceps tongue elevation and olecranon osteotomy in treatment of intra articular distal humerus fracture.
Olecranon osteotomyProcedure or surgery
Olecranon osteotomy procedure for distal intra articular humerus fracture.
| Study group | Role | What they receive |
|---|---|---|
| Olecranon osteotomy | Experimental | Olecranon osteotomy will be performed for intra articular distal humerus fracture and outcomes will be assessed Receives: Procedure: Olecranon osteotomy |
| Triceps tongue elevation | Experimental | Triceps tongue elevation will be performed for intra articular distal humerus fracture and outcomes will be assessed Receives: Procedure: Triceps tongue elevation |
What is being measured
The primary outcome is the main question the study is designed to answer.
MEPI score
It describes Pain,Stability, Range of motion and personal chores
Measured: At 3months and 6 month
MEPI score
It describes pain,stability, Range of motion and personal chores.
Measured: At 3months and 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Oct 2026
- Study start19 Sep 2026
- Primary completion19 May 2027 (estimated)
- Study completion19 May 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Intra Articular Distal Humerus FractureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 102 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Rawalpindi Teaching Hospital, District Headquarter Hospital, Rawalpindi
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Saad Ahmed Khokhar, Rawalpindi Teaching Hospital, District Headquarter Hospital, Rawalpindi
- Investigators
- Saad Riaz, FCPS, Study chair, Rawalpindi Teaching Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07860970
- Sponsor's protocol ID
- 3716/RTH,RWP
- Status last verified
- Sep 2026
- First submitted
- 30 Sep 2026
- Last updated
- 6 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individuals participant data is not publically available due to institutional privacy policy but can be availed from corresponding author on request
Study at a glance
From the registry record, last updated by the sponsor on 6 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Functional Outcomes Between Triceps Tongue Elevation vs Olecranon Osteotomy in Intra Articular Distal Humerus Fracture (IA-DH) Management
- ClinicalTrials.gov ID
- NCT07860970
- Acronym / sponsor ID
- 3716/RTH,RWP
- Conditions
- Intra Articular Distal Humerus Fracture
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 102 participants (estimated)
- Lead sponsor
- Rawalpindi Teaching Hospital, District Headquarter Hospital, RawalpindiOther government
- Study start
- 19 Sep 2026 (actual)
- Primary completion
- 19 May 2027 (estimated)
- Study completion
- 19 May 2027 (estimated)
- First posted
- 6 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Comparison of triceps tongue elevation vs olecranon osteotomy in intra articular distal humerus fracture management by doing Randomized control trial in trauma and orthopedic surgery department of Rawalpindi Teaching Hospital involving participants are 102 in 9 month duration by using MEPI score.
Detailed description
Comparison of triceps tongue elevation vs olecranon osteotomy in intra articular distal humerus fracture management by doing Randomized control trial in trauma and orthopedic surgery department of Rawalpindi Teaching Hospital involving participants are 102 with 51 in each in 9 month duration by using MEPI score.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Olecranon osteotomy | Experimental | Procedure: Olecranon osteotomyOlecranon osteotomy will be performed for intra articular distal humerus fracture and outcomes will be assessed |
| Triceps tongue elevation | Experimental | Procedure: Triceps tongue elevationTriceps tongue elevation will be performed for intra articular distal humerus fracture and outcomes will be assessed |
Who may qualify
- Ages
- 15 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Both Gender . Age 15-75 Years . (?) Radiologically confirmed intra-articular distal humerus fractures r Patients presenting within 7 days of injury
Key exclusion criteria (1 listed)
- Open fractures (Gustilo-Anderson Grade II or higher) . Pathological fractures (e.g., due to tumors or metabolic bone disease) r Previous elbow surgery or deformity on the affected limb Patients with associated neurovascular injury o Patients with comorbidities impairing rehabilitation (e.g., severe stroke, advanced arthritis) . Non-compliance with follow-up protocol
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Triceps tongue elevationCompare the outcomes of triceps tongue elevation and olecranon osteotomy in treatment of intra articular distal humerus fracture. | Procedure or surgery | Triceps tongue elevation |
| Olecranon osteotomyOlecranon osteotomy procedure for distal intra articular humerus fracture. | Procedure or surgery | Olecranon osteotomy |
Primary outcome
MEPI score
Time frame: At 3months and 6 month
It describes Pain,Stability, Range of motion and personal chores
MEPI score
Time frame: At 3months and 6 months
It describes pain,stability, Range of motion and personal chores.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Oct 2026.
- Individual participant dataSharing planned: No. Individuals participant data is not publically available due to institutional privacy policy but can be availed from corresponding author on request
Related trials for Intra Articular Distal Humerus Fracture
Not yet recruitingObservational study
Clinical Outcomes After Treatment of Distal Humerus Fractures With the LORRAINE 2.5/3.5 mm Distal Humerus System
Intra-Articular or Extra-Articular Distal Humerus Fracture, Distal Humerus Fracture
Recruiting
Opioid-Free Pain Treatment in Trauma Patients
Femoral Neck Fractures, Intertrochanteric Fractures
Recruiting
Elbow Hemiarthroplasty Versus ORIF for Distal Humeral Fractures
Distal Humerus Fracture, Comminuted Fracture
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Saad Riaz, FCPS study chair
Rawalpindi Teaching Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Triceps tongue elevation and Olecranon osteotomy in people with Intra Articular Distal Humerus Fracture, run by Rawalpindi Teaching Hospital, District Headquarter Hospital, Rawalpindi at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 6 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
MEPI score (time frame: At 3months and 6 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2026.